Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
As CEO, your immediate priority is patient safety, followed by ethical transparency, legal compliance, and stakeholder trust. Delaying disclosure risks lives, reputational damage, and severe legal consequences (e.g., criminal liability under the FDCA, shareholder lawsuits, or even a corporate manslaughter case).Read the full answer